In stomach adenocarcinoma, high expression of CENPN can be used as a novel biomarker for stomach adenocarcinoma, and silencing CENPN inhibits gastric adenocarcinoma cell proliferation through cell cycle protein E1 [14]. The gene discussed is CENPN; the disease is gastric adenocarcinoma.